Hansa Biopharma

is a leading company developing novel immunomodulatory enzymes for organ transplantation and acute autoimmune diseases with the aim of radically improving the lives of people with rare immunopathologies.

Continue Contact us
Stockholm
   HNSA SEK
2017 annual report       Investors